Clearside Biomedical Inc
(FRA:CLM)
€
0.885
0.065 (7.93%)
Market Cap: 69.14 Mil
Enterprise Value: 47.25 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 67/100 Clearside Biomedical Inc at JMP Securities Life Sciences Virtual Conference Transcript
Jun 16, 2021 / 05:00PM GMT
Release Date Price:
€3.05
(-3.48%)
Jon Wolleben
JMP Securities LLC - Analyst
Hi. Good afternoon, everybody. Jon Wolleben here; I'm a Senior Analyst at JMP Securities and want to welcome you to our annual life sciences conference. We're pleased to have the senior management team at Clearside Biomedical here to give us an update on their progress and their development programs. We have President, CEO George Lasezkay; and Chief Medical Officer and Chief Development Officer, Tom Ciulla, on the line. So, thanks for joining us today, guys.
George Lasezkay
Clearside Biomedical, Inc. - President and CEO
Great to be here. Thanks, Jon.
Tom Ciulla
Clearside Biomedical, Inc. - Chief Medical Officer and Chief Development Officer
Thanks for having us.
Jon Wolleben
JMP Securities LLC - Analyst
I think a great place to start for those not as familiar with the Clearside story, George, would maybe do an overview on the Company and what you're working on. And then, we can dig into some more details after that.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot